TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11407727

Group type: EXPERIMENTAL
Intervention: Troglitazone (200 mg bid)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glibenclamide (2.5 mg daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (age-, sex-, and risk factors-matched subjects without NIDDM)
Number of subjects: 12
Study: 9587532

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg per day for 4 weeks
Number of subjects: 57
Study: 8460390

Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation (4g Mg granulate verum, 6.7 mmol Mg aspartate)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study: 3809526

Group type: EXPERIMENTAL
Intervention: Caerulein 0.6 microgram/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 6
Study: 31597637

Group type: EXPERIMENTAL
Intervention: National quality improvement programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27837439

Group type: EXPERIMENTAL
Intervention: Prompt endocrine input
Number of subjects: 41

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 41
Study: 25613307

Group type: EXPERIMENTAL
Intervention: Patching during CEA
Number of subjects: 1151

Group type: COMPARATOR
Intervention: Primary closure during CEA
Number of subjects: 1151
Study: 23979789

Group type: EXPERIMENTAL
Intervention: Low-energy dense diet (LED)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Normal-energy dense diet (NED)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-energy dense diet (HED)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-energy dense diet (LED) and Normal-energy dense diet (NED)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison across 3 groups (LED, NED, HED)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dietary energy density (kcal/g)
Number of subjects: 60
Study: 21863204

Group type: COMPARATOR
Intervention: Psychological treatments (defined as interventions involving verbal communication between a therapist and a patient)
Number of subjects: 3010

Group type: COMPARATOR
Intervention: Control conditions (care-as-usual, waiting list, placebo, or another control group)
Number of subjects: 3010
Study: 19481810

Group type: EXPERIMENTAL
Intervention: Dilated pupil glare testing using the Brightness Acuity Tester (BAT) after dilation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Undilated pupil glare testing using the Brightness Acuity Tester (BAT)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Adjustment of dilated BAT results by the change in visual acuity (VA) from dilation
Number of subjects: 54
Study: 17655736

Group type: COMPARATOR
Intervention: Bed rest only (BR, n = 8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bed rest and nutrition countermeasure (BRN, n = 8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bed rest and concurrent exercise training countermeasure (BRE, n = 8)
Number of subjects: 24
Study: 15514963

Group type: EXPERIMENTAL
Intervention: Audio-visual relaxation training (RT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 100
Study: 11716384

Group type: EXPERIMENTAL
Intervention: Posterior-stabilized AMK total knee implants
Number of subjects: 143

Group type: COMPARATOR
Intervention: Cruciate-retaining AMK total knee implants
Number of subjects: 143
Study: 9205150

Group type: EXPERIMENTAL
Intervention: Bovine pericardial strips used to buttress staple lines
Number of subjects: 123

Group type: COMPARATOR
Intervention: No buttressing of staple lines
Number of subjects: 123
Study: 8518571

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 1686

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 1686
Study: 2883046

Group type: EXPERIMENTAL
Intervention: TCu220 IUD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delta T IUD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both IUDs (TCu220 and Delta T)
Number of subjects: 0
Study: 2565729

Group type: EXPERIMENTAL
Intervention: Adrenaline 0.3 mg subcutaneously
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Adrenaline 0.3 mg subcutaneously preceded by ICI 118,551 5 mg orally
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Salbutamol 8 mg orally
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: ICI 118,551
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 7
Study: 30920571

Group type: EXPERIMENTAL
Intervention: 4.75% soybean germ oil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 9.50% soybean germ oil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cholestyramine (0.50%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: High cholesterol diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-cholesterol diet
Number of subjects: 40
Study: 29167035

Group type: EXPERIMENTAL
Intervention: Balint groups (7 sessions of 1.5 hours over 3 months)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 299
Study: 25420030

Group type: EXPERIMENTAL
Intervention: Present Control Intervention
Number of subjects: 257

Group type: COMPARATOR
Intervention: Stress-information only comparison group
Number of subjects: 257
Study: 23728992

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention (theater play)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Environmental intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: No intervention (wait-control group)
Number of subjects: 80
Study: 21257263

Group type: EXPERIMENTAL
Intervention: 1 tablet of ibuprofen 200mg/paracetamol 500mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 tablets of ibuprofen 200mg/paracetamol 500mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 tablets of ibuprofen 200mg/codeine 12.8mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 tablets of paracetamol 500mg/codeine 15mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19320234

Group type: EXPERIMENTAL
Intervention: BILB 1941 60 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: BILB 1941 80 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: BILB 1941 100 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: BILB 1941 150 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: BILB 1941 200 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: BILB 1941 300 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: BILB 1941 450 mg
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 16813101

Group type: EXPERIMENTAL
Intervention: Ability grouping exercise program for lower fitness subjects (Group A)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Ability grouping exercise program for higher fitness subjects (Group B)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Single exercise program (Group C)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 124
Study: 15349901

Group type: EXPERIMENTAL
Intervention: TIPS
Number of subjects: 66

Group type: COMPARATOR
Intervention: Paracentesis plus albumin
Number of subjects: 66
Study: 10682299

Group type: EXPERIMENTAL
Intervention: Auditory temporal-spatial short-term memory tasks with sequences of bursts of white noise
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Auditory temporal-spatial short-term memory tasks with a 10-s delay
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Verbal and nonverbal secondary tasks
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Temporal errors in auditory memory tasks
Number of subjects: 8
Study: 9333147

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) plus hydroxyurea (HU) combination therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Didanosine (ddI) monotherapy
Number of subjects: 20
Study: 8226485

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 5 mg/kg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 2 x 2.5 mg/kg x day-1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF)
Number of subjects: 14
Study: 3801360

Group type: EXPERIMENTAL
Intervention: Norethisterone 5 mg/day
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Norethisterone 2.5 mg/day
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 28406860

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab
Number of subjects: 119
Study: 26946952

Group type: EXPERIMENTAL
Intervention: Basic intervention
Number of subjects: 845

Group type: EXPERIMENTAL
Intervention: Augmented intervention
Number of subjects: 845

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 845

Group type: EXPERIMENTAL
Intervention: All study participants
Number of subjects: 845
Study: 25168619

Group type: EXPERIMENTAL
Intervention: MiniArc (single-incision midurethral sling)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Monarc (transobturator midurethral sling)
Number of subjects: 193
Study: 23540683

Group type: EXPERIMENTAL
Intervention: l-lactate infusion (target concentration 3 mmol/L)
Number of subjects: 8

Group type: COMPARATOR
Intervention: saline infusion
Number of subjects: 8
Study: 20159123

Group type: EXPERIMENTAL
Intervention: Aquatic backward locomotion exercise
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 30
Study: 19126894

Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression (ASD) alone (n=50)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Arthroscopic subacromial decompression (ASD) plus ACJ excision (n=50, age-matched controls)
Number of subjects: 240
Study: 16673689

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study: 12197784

Group type: EXPERIMENTAL
Intervention: Ceramic-impregnated gloves
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo cotton gloves
Number of subjects: 93
Study: 11477816

Group type: EXPERIMENTAL
Intervention: Shengbaikuai Decoction (SBK)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nonchemotherapy group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Blank group
Number of subjects: 90
Study: 7893268

Group type: EXPERIMENTAL
Intervention: Multiple dose powder inhaler (MDPI; Easyhaler)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional metered dose inhaler (MDI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 2649954

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg
Number of subjects: 1630

Group type: COMPARATOR
Intervention: Piroxicam 20 mg
Number of subjects: 1630

Group type: COMPARATOR
Intervention: Diclofenac sodium retard 100 mg
Number of subjects: 1630

Group type: EXPERIMENTAL
Intervention: Tenoxicam
Number of subjects: 1630

Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 1630

Group type: COMPARATOR
Intervention: Diclofenac sodium retard
Number of subjects: 1630
Study: 1025317

Group type: EXPERIMENTAL
Intervention: Active needling
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Active needling followed by sham needling
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sham needling followed by active needling
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 29
Study: 31609689

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 63
Study: 30051975

Group type: EXPERIMENTAL
Intervention: 300 mg LY2495655 plus placebo
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 100 mg LY2495655 plus placebo
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: LY2495655 (either dose)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: LY2495655
Number of subjects: 125
Study: 27708124

Group type: EXPERIMENTAL
Intervention: Piña Colada (PC)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Classic Tobacco (CT)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: All flavours
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Peach Schnapps (PS)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Magnificent Menthol (MM), Classic Tobacco (CT), Vivid Vanilla (VV)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cherry Crush (CC), Piña Colada (PC), Peach Schnapps (PS)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sweetness
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Harshness
Number of subjects: 31
Study: 24737415

Group type: EXPERIMENTAL
Intervention: Adjuvant imatinib 400 mg/day for 12 months
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Adjuvant imatinib 400 mg/day for 36 months
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Imatinib for 12 months
Number of subjects: 358

Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 358
Study: 23202613

Group type: EXPERIMENTAL
Intervention: TRO40303
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18675959

Group type: EXPERIMENTAL
Intervention: GnRHa/chemotherapy cotreatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Chemotherapy alone (Control)
Number of subjects: 80
Study: 18065071

Group type: EXPERIMENTAL
Intervention: Sequential practice trials with short movement goal
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sequential practice trials with long movement goal
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Change in movement goal for the second movement
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Separate planning of sequential aiming movements
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Interference due to practice organization and switching the task's goal
Number of subjects: 20
Study: 15736608

Group type: EXPERIMENTAL
Intervention: 200 mg or 400 mg of modafinil
Number of subjects: 15
Study: 12393276

Group type: EXPERIMENTAL
Intervention: rIFN(‐)
Number of subjects: 65

Group type: COMPARATOR
Intervention: rIFN(‐) + Ara‐C
Number of subjects: 65
Study: 9523655

Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT) using the Leo Microthermer system
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no further treatment)
Number of subjects: 67
Study: 8732145

Group type: EXPERIMENTAL
Intervention: Chinese integrated medicine (CIM)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 2649640

Group type: EXPERIMENTAL
Intervention: Sinemet CR4
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sinemet 25/100 (STD)
Number of subjects: 14
Study: 413493

Group type: EXPERIMENTAL
Intervention: Nebulized sodium cromoglycate solution
Number of subjects: 17
Study: 31188727

Group type: EXPERIMENTAL
Intervention: Pegaspargase (PEG‐ASP)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Native Escherichia coli asparaginase (L‐ASP)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Intrathecal therapy (IT)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Anti-PEG-ASP antibodies
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Occurrence of angioedema with first reaction
Number of subjects: 598
Study: 28430159

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight fucoidan (LMF) as a supplemental therapy to chemotarget agents
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (chemotarget agents only)
Number of subjects: 54
Study: 26116078

Group type: EXPERIMENTAL
Intervention: Local anaesthetic wound infiltration (LAI)
Number of subjects: 0
Study: 23396142

Group type: EXPERIMENTAL
Intervention: Surgery-induced weight loss
Number of subjects: 32

Group type: COMPARATOR
Intervention: Diet-induced weight loss
Number of subjects: 32
Study: 21516182

Group type: EXPERIMENTAL
Intervention: Children (aged 8-13)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Young adults (aged 19-26)
Number of subjects: 30
Study: 19450177

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational studies with statistical adjustment for lead-time
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational studies without statistical adjustment
Number of subjects: 0
Study: 17934385

Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychoeducation and healthy lifestyle counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Careful selection of medications and routine screening for cardiovascular risk factors
Number of subjects: 0
Study: 15467597

Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg b.i.d.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study: 11408152

Group type: EXPERIMENTAL
Intervention: Intelisite capsule
Number of subjects: 8
Study: 9562581

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin-2
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Recombinant human interferon alfa-2a
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin-2 plus interferon alfa-2a
Number of subjects: 425

Group type: COMPARATOR
Intervention: Overall survival
Number of subjects: 425

Group type: COMPARATOR
Intervention: Toxic effects of therapy
Number of subjects: 425
Study: 1820985

Group type: EXPERIMENTAL
Intervention: Mitoxantrone alone
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: VeMP regimen (VP‐16, Mitoxantrone, Prednisolone)
Number of subjects: 35
Study: 7092136

Group type: EXPERIMENTAL
Intervention: Single intravenous dose of metronidazole
Number of subjects: 131

Group type: COMPARATOR
Intervention: Physiological saline placebo
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Perforated appendix cases
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Both groups (metronidazole and placebo)
Number of subjects: 131
Study: 30681559

Group type: COMPARATOR
Intervention: Methylene blue localization group (n=47)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Modified localization group (n=32)
Number of subjects: 79
Study: 28993069

Group type: EXPERIMENTAL
Intervention: Combination A (silicone-hydrogel CLs)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination B (silicone-hydrogel CLs)
Number of subjects: 20
Study: 25775634

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied to a representative plaque for 9 months
Number of subjects: 25

Group type: COMPARATOR
Intervention: Vehicle applied to a control plaque for 9 months
Number of subjects: 25
Study: 24216543

Group type: EXPERIMENTAL
Intervention: Amino acid-based formula (AAF) with synbiotics
Number of subjects: 145

Group type: COMPARATOR
Intervention: Commercially available AAF
Number of subjects: 145
Study: 22509860

Group type: EXPERIMENTAL
Intervention: Distal protection device
Number of subjects: 2783

Group type: COMPARATOR
Intervention: Control (PCI alone)
Number of subjects: 2783
Study: 20224285

Group type: EXPERIMENTAL
Intervention: Formula F plus donepezil
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo plus donepezil
Number of subjects: 52
Study: 18765643

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Levobupivacaine
Number of subjects: 60
Study: 15962065

Group type: COMPARATOR
Intervention: Intravenous administration of ketoprofen 100 mg (Group C)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intravenous administration of tenoxicam 40 mg (Group T)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intravenous administration of physiological serum 0.9% (Group F)
Number of subjects: 19
Study: 14756017

Group type: EXPERIMENTAL
Intervention: Supervised physical training (daily exercise program for 21 +/- 10 days)
Number of subjects: 74
Study: 10477986

Group type: EXPERIMENTAL
Intervention: Pain‐Free (oxalate‐containing pre‐polymerized resin suspension)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DentinBloc (0.7% fluoride solution)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (distilled water)
Number of subjects: 10
Study: 1372668

Group type: EXPERIMENTAL
Intervention: Complement activating membrane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-complement activating membrane
Number of subjects: 0
Study: 3834830

Group type: EXPERIMENTAL
Intervention: Suppositories containing sodium salicylate and Brij 35
Number of subjects: 6

Group type: COMPARATOR
Intervention: Suppositories without adjuvants
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium salicylate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Suppositories (general)
Number of subjects: 6
Study: 31578173

Group type: EXPERIMENTAL
Intervention: Apalutamide (four 60 mg tablets, once daily)
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1052
Study: 29782276

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 27395
Study: 27310958

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 25 μg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (spinal anesthesia with bupivacaine supplemented with normal saline)
Number of subjects: 60
Study: 24383843

Group type: EXPERIMENTAL
Intervention: imatinib 800 mg daily (IM800)
Number of subjects: 153

Group type: COMPARATOR
Intervention: imatinib 400 mg daily (IM400)
Number of subjects: 153
Study: 22828088

Group type: EXPERIMENTAL
Intervention: Valsartan and moxonidine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Bendroflumethiazide and amlodipine
Number of subjects: 42
Study: 19943990

Group type: EXPERIMENTAL
Intervention: Total sleep time (actigraphic measurement)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Time awake after initial sleep onset (actigraphic measurement)
Number of subjects: 45
Study: 17611565

Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation (SCT)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Geno-identical allogeneic SCT
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Donor lymphocyte infusions
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Unrelated donor transplantation
Number of subjects: 421

Group type: COMPARATOR
Intervention: No specific intervention
Number of subjects: 421